Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19
pandemic due to their impaired response to infection and vaccination. Specifically, patients …

Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

Immunocompromised patients, including those with inborn errors of immunity (IEI), may be at
increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med …

Following the third booster dose of the mRNA vaccine, Common Variable Immune
Deficiencies (CVID) patients may not produce specific antibodies against the virus spike …

Morbidity and mortality of COVID-19 is increased in patients with inborn errors of immunity
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …

Previous studies on immune responses following COVID-19 vaccination in patients with
common variable immunodeficiency (CVID) were inconclusive with respect to the ability of …

CVID patients have an increased susceptibility to vaccine-preventable infections. The
question on the potential benefits of immunization of CVID patients against SARS-CoV-2 …

Background Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore …

Purpose Limited data is available on the effect of COVID-19 vaccination in
immunocompromised individuals. Here, we provide the results from vaccinating a single …